Literature DB >> 24767860

Papillary renal cell carcinoma revisited: a comprehensive histomorphologic study with outcome correlations.

Joshua I Warrick1, Alex Tsodikov2, Lakshmi P Kunju3, Arul M Chinnaiyan4, Ganesh S Palapattu5, Todd M Morgan5, Ajjai Alva6, Scott Tomlins7, Angela Wu1, Jeffrey S Montgomery5, Khaled S Hafez5, J Stuart Wolf5, Alon Z Weizer5, Rohit Mehra8.   

Abstract

Papillary renal cell carcinoma (P-RCC) is the second most common type of malignant renal epithelial tumor and can be subclassified into type 1, which demonstrates simple cuboidal low-grade epithelium and type 2, which demonstrates pseudostratified high-grade epithelium with abundant eosinophilic cytoplasm. Despite this clinically useful subclassification, P-RCCs exhibit considerable histomorphologic diversity, with many cases having features differing from classically described type 1 and type 2 tumors. To our knowledge, there has been no recent study that has methodically evaluated the histomorphologic features of a series of P-RCCs. To address this, we evaluated a cohort of P-RCCs diagnosed between 1997 and 2004 with long-term clinical follow-up data (n = 56). Histomorphologic features previously described in the spectrum of type 1 and type 2 P-RCCs were recorded for each tumor, including nuclear grade, complete tumor capsule, and cytoplasmic eosinophilia as well as several other features. The current TNM staging (American Joint Committee on Cancer, seventh edition) was assigned to all cases. Histomorphologic features were diverse, demonstrating classic type 1 P-RCC and classic type 2 P-RCC morphology and several tumors with nonclassic features. Four patients in this cohort had distant metastasis. The primary tumor was equally divided between type 1 (2 cases) and type 2 (2 cases) morphology in the cases with metastasis. All P-RCC cases with metastases demonstrated presence of high nuclear grade and high tumor stage in the primary tumor. Cluster analysis using staging parameters and histomorphologic features divided tumors into 2 primary clusters. All primary tumors associated with metastasis were in the same cluster.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Nuclear grade; Papillary renal cell carcinoma; Tumor stage

Mesh:

Year:  2014        PMID: 24767860      PMCID: PMC6180318          DOI: 10.1016/j.humpath.2014.02.004

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  27 in total

1.  Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.

Authors:  B Delahunt; J N Eble; M R McCredie; P B Bethwaite; J H Stewart; A M Bilous
Journal:  Hum Pathol       Date:  2001-06       Impact factor: 3.466

2.  Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases.

Authors:  Yves Allory; Delphine Ouazana; Eric Boucher; Nicolas Thiounn; Annick Vieillefond
Journal:  Virchows Arch       Date:  2003-04-04       Impact factor: 4.064

3.  Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors.

Authors:  B Delahunt; J N Eble
Journal:  Mod Pathol       Date:  1997-06       Impact factor: 7.842

4.  Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma.

Authors:  William R Sukov; Christine M Lohse; Bradley C Leibovich; R Houston Thompson; John C Cheville
Journal:  J Urol       Date:  2011-11-16       Impact factor: 7.450

5.  Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases.

Authors:  R Mancilla-Jimenez; R J Stanley; R A Blath
Journal:  Cancer       Date:  1976-12       Impact factor: 6.860

6.  Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.

Authors:  Maria F Serrano; Matthew Katz; Yan Yan; Adam S Kibel; Peter A Humphrey
Journal:  Cancer       Date:  2008-08-01       Impact factor: 6.860

7.  Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features.

Authors:  Lakshmi P Kunju; Kirk Wojno; J Stuart Wolf; Liang Cheng; Rajal B Shah
Journal:  Hum Pathol       Date:  2007-10-18       Impact factor: 3.466

8.  Papillary adenocarcinoma of kidney. II. Radiographic and biologic characteristics.

Authors:  R H Bard; B Lord; F Fromowitz
Journal:  Urology       Date:  1982-01       Impact factor: 2.649

9.  Papillary adenocarcinoma of kidney: a new perspective.

Authors:  S Boczko; F B Fromowitz; R H Bard
Journal:  Urology       Date:  1979-11       Impact factor: 2.649

10.  Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.

Authors:  Vitaly Margulis; Pheroze Tamboli; Surena F Matin; David A Swanson; Christopher G Wood
Journal:  Cancer       Date:  2008-04-01       Impact factor: 6.860

View more
  6 in total

1.  Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.

Authors:  Levente Kuthi; Alex Jenei; Adrienn Hajdu; István Németh; Zoltán Varga; Zoltán Bajory; László Pajor; Béla Iványi
Journal:  Pathol Oncol Res       Date:  2016-12-28       Impact factor: 3.201

2.  Prognostic factors for the survival of patients with papillary renal cell carcinoma after surgical management.

Authors:  W Ren; X Gao; X Zhang; J Hu; H Li; X Zu
Journal:  Clin Transl Oncol       Date:  2019-07-17       Impact factor: 3.405

Review 3.  Therapeutic challenges in renal cell carcinoma.

Authors:  Justin C Penticuff; Natasha Kyprianou
Journal:  Am J Clin Exp Urol       Date:  2015-08-08

4.  Mucinous tubular and spindle cell carcinoma and solid variant papillary renal cell carcinoma: a clinicopathologic comparative analysis of four cases with similar molecular genetics datum.

Authors:  Yanling Zhang; Xiang Yong; Qiong Wu; Xiaoli Wang; Qiong Zhang; Shiwu Wu; Donghong Yu
Journal:  Diagn Pathol       Date:  2014-12-05       Impact factor: 2.644

5.  Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational Study.

Authors:  Yu-Zheng Ge; Lu-Wei Xu; Zheng Xu; Ran Wu; Hui Xin; Meng Zhu; Tian-Ze Lu; Li-Guo Geng; Hao Liu; Chang-Cheng Zhou; Peng Yu; You-Cai Zhao; Zhi-Kai Hu; Yan Zhao; Liu-Hua Zhou; Jian-Ping Wu; Wen-Cheng Li; Jia-Geng Zhu; Rui-Peng Jia
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

6.  Whether histologic subtyping affect the oncological outcomes of patients with papillary renal cell carcinoma: evidence from a systematic review and meta-analysis.

Authors:  Shengwei Xiong; Weijie Zhu; Xinfei Li; Yanfei Yu; Kunlin Yang; Lei Zhang; Yue Mi; Xuesong Li; Liqun Zhou
Journal:  Transl Androl Urol       Date:  2021-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.